Vasoconstrictor-induced heterologous down-regulation of vascular atrial natriuretic peptide receptor

Eur J Pharmacol. 1989 May 30;164(3):603-6. doi: 10.1016/0014-2999(89)90273-2.

Abstract

Long-term (24 h) pretreatment of cultured rat vascular smooth muscle cells with 100 nM angiotensin and 1 microM vasopressin induced a marked reduction of the maximal binding capacity of atrial natriuretic peptide (ANP) receptors in a fashion similar to that induced by phorbol ester. The down-regulation of the receptors induced by vasoconstrictors and phorbol ester was concomitantly associated with an attenuation of ANP-stimulated cGMP accumulation. These data suggest that vasoconstrictor-induced activation of protein kinase C is involved in the mechanism of heterologous down-regulation of vascular ANP receptors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin II / physiology
  • Animals
  • Arginine Vasopressin / physiology
  • Cyclic GMP / metabolism
  • Humans
  • In Vitro Techniques
  • Iodine Radioisotopes
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / metabolism
  • Piperidines / metabolism
  • Rats
  • Receptors, Atrial Natriuretic Factor
  • Receptors, Cell Surface / physiology*
  • Tetradecanoylphorbol Acetate / pharmacology
  • Vasoconstrictor Agents / pharmacology*

Substances

  • Iodine Radioisotopes
  • Piperidines
  • Receptors, Cell Surface
  • Vasoconstrictor Agents
  • Angiotensin II
  • Arginine Vasopressin
  • preclamol
  • Receptors, Atrial Natriuretic Factor
  • Cyclic GMP
  • Tetradecanoylphorbol Acetate